| Nose-to-brain delivery of chrysin transfersomal and composite vesicles in doxorubicin-induced cognitive impairment in rats: Insights on formulation, oxidative stress and TLR4 … SS Ibrahim, OGA Elseoud, MH Mohamedy, MM Amer, YY Mohamed, ... Neuropharmacology 197, 108738, 2021 | 47 | 2021 |
| In vivo cellular and molecular gastroprotective mechanisms of chrysin; Emphasis on oxidative stress, inflammation and angiogenesis MY George, A Esmat, MG Tadros, E El-Demerdash European journal of pharmacology 818, 486-498, 2018 | 42 | 2018 |
| Potential therapeutic antipsychotic effects of Naringin against ketamine-induced deficits in rats: Involvement of Akt/GSK-3β and Wnt/β-catenin signaling pathways MY George, ET Menze, A Esmat, MG Tadros, E El-Demerdash Life Sciences, 117535, 2020 | 34 | 2020 |
| Insights into the neuroprotective effects of Salvia officinalis L. and Salvia microphylla Kunth in the memory impairment rat model IM Ayoub, MY George, ET Menze, M Mahmoud, M Botros, M Essam, ... Food & Function 13 (4), 2253-2268, 2022 | 29 | 2022 |
| Chemical characterization of the polyphenolic rich fraction of Thunbergia erecta and its therapeutic potential against doxorubicin and cyclophosphamide-induced cognitive … MIG El-Din, MY George, FS Youssef Journal of Ethnopharmacology 307, 116213, 2023 | 12 | 2023 |
| Design and Evaluation of chrysin-loaded nanoemulsion against lithium/pilocarpine-induced status epilepticus in rats; emphasis on formulation, neuronal excitotoxicity, oxidative … MY George, MO El-Derany, Y Ahmed, M Zaher, C Ibrahim, H Waleed, ... Expert Opinion on Drug Delivery 20 (1), 159-174, 2023 | 11 | 2023 |
| Naringin treatment improved main clozapine‐induced adverse effects in rats; emphasis on weight gain, metabolic abnormalities, and agranulocytosis MY George, ET Menze, A Esmat, MG Tadros, E El‐Demerdash Drug Development Research 82 (7), 980-989, 2021 | 8 | 2021 |
| Phytochemical profiling and neuroprotective activity of Callistemon subulatus leaves against cyclophosphamide-induced chemobrain O Rabie, HAS El-Nashar, MY George, TA Majrashi, T Al-Warhi, ... Biomedicine & Pharmacotherapy 167, 115596, 2023 | 7 | 2023 |
| Design and synthesis of novel 4-fluorobenzamide-based derivatives as promising anti-inflammatory and analgesic agents with an enhanced gastric tolerability and COX-inhibitory … PA Halim, HH Georgey, MY George, AM El Kerdawy, MF Said Bioorganic Chemistry 115, 105253, 2021 | 7 | 2021 |
| Neuromodulatory effect of vardenafil on aluminium chloride/d-galactose induced Alzheimer’s disease in rats: emphasis on amyloid-beta, p-tau, PI3K/Akt/p53 … HH Awad, MA Desouky, A Zidan, M Bassem, A Qasem, M Farouk, ... Inflammopharmacology 31 (5), 2653-2673, 2023 | 6 | 2023 |
| Roflumilast escalates α-synuclein aggregate degradation in rotenone-induced Parkinson's disease in rats: Modulation of the ubiquitin-proteasome system and endoplasmic reticulum … MA Desouky, MY George, HE Michel, DA Elsherbiny Chemico-Biological Interactions 379, 110491, 2023 | 6 | 2023 |
| Nose to brain delivery of naringin-loaded chitosan nanoparticles for potential use in oxaliplatin-induced chemobrain in rats: impact on oxidative stress, cGAS/STING and HMGB1 … DMF Hanna, J Youshia, SF Fahmy, MY George Expert Opinion on Drug Delivery 20 (12), 1859-1873, 2023 | 4 | 2023 |
| L-carnitine modulates cognitive impairment induced by doxorubicin and cyclophosphamide in rats; insights to oxidative stress, inflammation, synaptic plasticity, liver/brain … OF Morid, ET Menze, MG Tadros, MY George Journal of Neuroimmune Pharmacology 18 (3), 310-326, 2023 | 4 | 2023 |
| Nose-to-brain delivery of 18β-Glycyrrhetinic acid using optimized lipid nanocapsules: A novel alternative treatment for Alzheimer’s disease SR Gad, RI El-Gogary, MY George, RM Hathout International Journal of Pharmaceutics 645, 123387, 2023 | 3 | 2023 |
| Clotrimazole ameliorates chronic mild stress-induced depressive-like behavior in rats; crosstalk between the HPA, NLRP3 inflammasome, and Wnt/β-catenin pathways SF Fawzi, HE Michel, ET Menze, MG Tadros, MY George International Immunopharmacology 127, 111354, 2024 | 1 | 2024 |
| Mechanisms and Protective Strategies in Cognitive Impairment Induced by Combination of Doxorubicin and Cyclophosphamide NK Gamal, RN Elnaga, MY George Archives of Pharmaceutical Sciences Ain Shams University 8 (1), 109-121, 2024 | | 2024 |
| The Cardioprotective and Anticancer Effects of SGLT2 Inhibitors: JACC: CardioOncology State-of-the-Art Review MS Dabour, MY George, MR Daniel, AH Blaes, BN Zordoky JACC: CardioOncology, 2024 | | 2024 |
| Empagliflozin repurposing in Parkinson’s disease; modulation of oxidative stress, neuroinflammation, AMPK/SIRT-1/PGC-1α, and wnt/β-catenin pathways NN Mohammed, MG Tadros, MY George Inflammopharmacology 32 (1), 777-794, 2024 | | 2024 |
| In vivo hepatoprotective and nephroprotective effects of Stenocarpus sinuatus leaf extract against ifosfamide‐induced toxicity in rats MM Younis, IM Ayoub, MY George, NM Mostafa, OA Eldahshan Archiv der Pharmazie, e2300438, 2024 | | 2024 |
| Lactoferrin ameliorates carfilzomib-induced renal and pulmonary deficits: Insights to the inflammasome NLRP3/NF-κB and PI3K/Akt/GSK-3β/MAPK axes CN Habib, AE Ali, NH Anber, MY George Life Sciences 335, 122245, 2023 | | 2023 |
